BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Scantek Medical, Inc. (SKML) Receives $250,000 Loan And $100,000 For The Completion Of A Clinical Study


10/19/2005 5:12:33 PM

CEDAR KNOLLS, N.J., Jan. 25, 2005 (PRIMEZONE) -- Scantek Medical, Inc. (Pink Sheets:SKML) announced today that on December 3, 2004, it entered into an Agreement (the "Agreement") with Life Medical Technologies, Inc. ("Life Medical") pursuant to which Life Medical, subject to certain terms and conditions, would have received an option to distribute BreastCare(tm)/BreastAlert(tm) Differential Temperature Sensor/Breast Abnormality Indicator device ("BreastCare(tm)") in the United States. However, almost immediately after the execution of the Agreement, Life Medical and Scantek determined to modify the Agreement and re-commenced negotiations. Negotiations with respect to the modifications to the Agreement are still in progress. As part of the transaction, Scantek received from Life Medical (i) a $250,000 loan (the "Loan") which is due on June 5, 2006 and bears interest at a rate of 8% per annum and (ii) $100,000 to be used towards the completion of a clinical study by Dr. Virgilio Sacchini.

Read at Prime Zone

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES